{"id":"W2807279220","doi":"10.1016/j.jcjd.2018.05.008","title":"Semaglutide: Review and Place in Therapy for Adults With Type 2 Diabetes","year":2018,"lang":"en","type":"review","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk; Gilead Sciences; Sanofi; Pfizer","keywords":"Semaglutide; Medicine; Dulaglutide; Sitagliptin; Type 2 diabetes; Exenatide; Metformin; Glycated hemoglobin; Glycemic; Clinical trial; Placebo; Internal medicine; Weight loss; Insulin glargine; Diabetes mellitus; Pharmacology; Insulin; Endocrinology; Liraglutide; Obesity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007641012,0.0005917143,0.002211943,0.002146998,0.0002320417,0.001214225,0.0008767503,0.0009523909,0.004016602],"category_scores_gemma":[0.001726214,0.0002353603,0.001084487,0.002768071,0.0004009865,0.0008397208,0.000596052,0.001482111,0.0006516019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00064988,"about_ca_system_score_gemma":0.001980797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004158019,"about_ca_topic_score_gemma":0.01099542,"domain_scores_codex":[0.9996395,0.00006741082,0.000108098,0.0000450896,0.0001124738,0.00002739524],"domain_scores_gemma":[0.999158,0.0004337276,0.0002068424,0.00001123946,0.0001360358,0.00005411726],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003947156,0.00007263086,0.00065716,0.07324865,0.0008078924,0.0001970354,0.00007982449,0.0002117438,0.0004124397,0.001725673,0.03569692,0.8864954],"study_design_scores_gemma":[0.0004707818,0.0003312519,0.004398199,0.05405582,0.003762932,0.002351061,0.0002334995,0.000220957,0.0002827587,0.001526961,0.9323025,0.00006321588],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008360216,0.9994217,0.00001576994,0.0001601378,0.00009527065,0.000002091866,0.00001678514,0.000002221612,0.0002023793],"genre_scores_gemma":[0.0008091046,0.9986389,0.00008160256,0.0002504212,0.00008513849,0.000003162977,0.00001924316,7.736674e-7,0.000111585],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004158019,"threshold_uncertainty_score":0.01343691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02438146984910394,"score_gpt":0.2820044215583799,"score_spread":0.257622951709276,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}